Rapid analysis of fluoxetine and its metabolite in plasma by LC-MS with column-switching approach.
A rapid and sensitive method was developed for the simultaneous determination of fluoxetine and its primary metabolite, norfluoxetine, in plasma. It was based on a column-switching approach with a precolumn packed with large size particles coupled with a liquid chromatography-electrospray ionisation-mass spectrometry (LC-ESI-MS). After a simple centrifugation, plasma samples were directly injected onto the precolumn. The endogenous material was excluded thanks to a high flow rate while analytes were retained by hydrophobic interactions. Afterwards, the target compounds were eluted in back flush mode to an octadecyl analytical column and detected by ESI-MS. The overall analysis time per sample, from plasma sample preparation to data acquisition, was achieved in less than 4 min. Method performances were evaluated. The method showed good linearity in the range of 25-1000 ng mL(-1) with a determination coefficient higher than 0.99. Limits of quantification were estimated at 25 ng mL(-1) for fluoxetine and norfluoxetine. Moreover, method precision was better than 6% in the studied concentration range. These results demonstrated that the method could be used to quantify target compounds. Finally, the developed assay proved to be suitable for the simultaneous analysis of fluoxetine and its metabolite in real plasma samples.
Souverain
S
S
Laboratory of Analytical Pharmaceutical Chemistry, School of Pharmacy, University of Geneva, 20 bvd d'Yvoy, 1211, Geneva 4, Switzerland.
Mottaz
M
M
Cherkaoui
S
S
Veuthey
J-L
JL
D000284:Administration, Oral; D018687:Antidepressive Agents, Second-Generation / Q000008:administration & dosage / Q000097:blood* / Q000378:metabolism; D002851:Chromatography, High Pressure Liquid / Q000379:methods*; D005473:Fluoxetine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000097:blood* / Q000378:metabolism; D006801:Humans; D021241:Spectrometry, Mass, Electrospray Ionization / Q000379:methods*; D013997:Time Factors
D018687:Antidepressive Agents, Second-Generation; C481126:methylfluoxetine; D005473:Fluoxetine; C036139:norfluoxetine